Active Infection with Cytomegalovirus and Herpes Group Viruses in Children Receiving Corticosteroid Therapy

Chiba, Shunzo; Ikeda, Shigeru; Agatsuma, Yoshitaka; Nakao, Tooru; Saheki, Yoshito

doi:10.1620/tjem.106.265

Cited by 6 publications

(1 citation statement)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…C. albicans is the most common Candida species; however, the emerging species such as C. auris is a highly invasive and multidrug-resistant yeast causing complicated conditions [43,44]. COVID-19-associated candidiasis (CAC) has been reported in a number of cases until now [43], and C. auris was the most [214,215], meningitis [216,217], disseminated infection [218], pneumonia [219] Pneumocystis jiroveci (carinii) pneumonia [220,221] Aspergillosis [222][223][224][225] Candidiasis: oral candidiasis [226], esophageal candidiasis [227], disseminated [228] Mucormycosis: pulmonary [229,230], disseminated [230], cutaneous [231,232], gastric perforation [233], maxillary sinus [234] Strongyloidiasis: Severe [235][236][237][238], disseminated [239,240], cerebral involvement [239], pulmonary strongyloidiasis [241], hyperinfection [242] Tuberculosis (pulmonary) [243] Cytomegalovirus (CMV) infection [244,245] Toxoplasmosis: ocular toxoplasmosis [154][155][156], cerebral toxoplasmosis [157,158] JAKs inhibitor...…”

Section: Candidiasismentioning

confidence: 99%

COVID-19-associated opportunistic infections: a snapshot on the current reports

2021

View full text Add to dashboard Cite

Treatment of the novel Coronavirus Disease 2019 (COVID-19) remains a complicated challenge, especially among patients with severe disease. In recent studies, immunosuppressive therapy has shown promising results for control of the cytokine storm syndrome (CSS) in severe cases of COVID-19. However, it is well documented that immunosuppressive agents ( e.g., corticosteroids and cytokine blockers) increase the risk of opportunistic infections. On the other hand, several opportunistic infections were reported in COVID-19 patients, including Aspergillus spp . , Candida spp . , Cryptococcus neoformans , Pneumocystis jiroveci ( carinii ), mucormycosis, Cytomegalovirus (CMV), Herpes simplex virus (HSV), Strongyloides stercoralis, Mycobacterium tuberculosis, and Toxoplasma gondii . This review is a snapshot about the main opportunistic infections that reported among COVID-19 patients. As such, we summarized information about the main immunosuppressive agents that were used in recent clinical trials for COVID-19 patients and the risk of opportunistic infections following these treatments. We also discussed about the main challenges regarding diagnosis and treatment of COVID-19-associated opportunistic infections (CAOIs). Supplementary Information The online version contains supplementary material available at 10.1007/s10238-021-00751-7.

show abstract

Section: Candidiasismentioning

confidence: 99%

COVID-19-associated opportunistic infections: a snapshot on the current reports

2021

View full text Add to dashboard Cite

show abstract

Erythema nodosum

Blomgren

1974

Seminars in Arthritis and Rheumatism

View full text Add to dashboard Cite

Erythema Nodosum

White

1985

Dermatologic Clinics

View full text Add to dashboard Cite

Erythema nodosum is the most common and, in its classic form, the most easily recognized cause of inflammatory nodules on the legs. It is characterized by inflammatory, tender, nonulcerating, nonscarring nodules that are typically multiple and bilateral. The rather characteristic clinical presentation can be attributable to one of many causes or associated with a wide spectrum of systemic diseases. Diagnosis, evaluation, and treatment are discussed.

show abstract

Active Infection with Cytomegalovirus and Herpes Group Viruses in Children Receiving Corticosteroid Therapy

Cited by 6 publications

References 23 publications

COVID-19-associated opportunistic infections: a snapshot on the current reports

COVID-19-associated opportunistic infections: a snapshot on the current reports

Erythema nodosum

Erythema Nodosum

Contact Info

Product

Resources

About